{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:21:50Z","timestamp":1788852110782,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.xphs.2021.02.016","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T16:49:59Z","timestamp":1613666999000},"page":"2301-2310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development and Qualification of a Physiologically Based Pharmacokinetic Model of Finasteride and Minoxidil Following Scalp Application"],"prefix":"10.1016","volume":"110","author":[{"given":"Arpar","family":"Ngampanya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udomsak","family":"Udomnilobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakawadee","family":"Sermsappasuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natapol","family":"Pornputtapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boonsri","family":"Ongpipattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikunjkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suree","family":"Jianmongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomayant","family":"Prueksaritanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2021.02.016_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/psp4.12421","article-title":"Current scientific considerations to verify physiologically-based pharmacokinetic models and their implications for locally acting products","volume":"8","author":"Zhao","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.xphs.2021.02.016_bib3","series-title":"Towards Development and Validation of the Dermal PBPK Model for Virtual Bioequivalence - Model Description and Validation Case Studies 2015 GRC Barrier Function of Mammalian Skin Conference","author":"Patel","year":"2015"},{"key":"10.1016\/j.xphs.2021.02.016_bib5","series-title":"Predicting Diclofenac Systemic and Synovial Fluid Concentrations after Dermal Application Using the Multi-phase Multi-Layer MechDermA PBPK Model","author":"Polak","year":"2017"},{"issue":"7","key":"10.1016\/j.xphs.2021.02.016_bib6","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/jps.23155","article-title":"Prediction of concentration\u2013time profile and its inter-individual variability following the dermal drug absorption","volume":"101","author":"Polak","year":"2012","journal-title":"J\u00a0Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2021.02.016_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/1346-8138.14470","article-title":"Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version","volume":"45","author":"Manabe","year":"2018","journal-title":"J\u00a0Dermatol"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.016_bib8","first-page":"457","article-title":"A\u00a0systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women","volume":"17","author":"Lee","year":"2018","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.016_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/j.1875-9114.1995.tb04389.x","article-title":"Pharmacodynamic modeling of finasteride, a 5 alpha-reductase inhibitor","volume":"15","author":"Ko","year":"1995","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.xphs.2021.02.016_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2133.1999.03042.x","article-title":"Immunohistochemical localization of types 1 and 2 5 alpha-reductase in human scalp","volume":"141","author":"Bayne","year":"1999","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.xphs.2021.02.016_bib11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/asj\/sjv079","article-title":"A\u00a0comprehensive examination of topographic thickness of skin in the human face","volume":"35","author":"Chopra","year":"2015","journal-title":"Aesthet Surg J"},{"issue":"6","key":"10.1016\/j.xphs.2021.02.016_bib12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/1523-1747.ep12540633","article-title":"The thickness of human scalp: normal and bald","volume":"58","author":"Hori","year":"1972","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.016_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"issue":"10","key":"10.1016\/j.xphs.2021.02.016_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s004030050453","article-title":"Number of cell layers of the stratum corneum in normal skin - relationship to the anatomical location on the body, age, sex and physical parameters","volume":"291","author":"Ya-Xian","year":"1999","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.016_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.016_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jps.10005","article-title":"Prediction of pharmacokinetics prior to in\u00a0vivo studies. 1. Mechanism-based prediction of volume of distribution","volume":"91","author":"Poulin","year":"2002","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.016_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0090-9556(25)08559-9","article-title":"Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans","volume":"20","author":"Carlin","year":"1992","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.016_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-198122040-00001","article-title":"Minoxidil: a review of its pharmacological properties and therapeutic use","volume":"22","author":"Campese","year":"1981","journal-title":"Drugs"},{"issue":"25","key":"10.1016\/j.xphs.2021.02.016_bib19","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1021\/jm9810102","article-title":"Correlation of human jejunal permeability (in\u00a0vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach","volume":"41","author":"Winiwarter","year":"1998","journal-title":"J\u00a0Med Chem"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.016_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/j.1552-4604.1989.tb03307.x","article-title":"The pharmacokinetics of 2.5- to 10-mg oral doses of minoxidil in healthy volunteers","volume":"29","author":"Fleishaker","year":"1989","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2021.02.016_bib21","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"Rodgers","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2021.02.016_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.5414\/CP202119","article-title":"A\u00a0novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers","volume":"52","author":"Caserini","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.016_bib24","first-page":"550","article-title":"The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia","volume":"41","author":"Drake","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.016_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1677\/joe.0.0570111","article-title":"The metabolism of testosterone by human male scalp skin","volume":"57","author":"Bingham","year":"1973","journal-title":"J\u00a0Endocrinol"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.016_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.addr.2012.04.011","article-title":"Improved input parameters for diffusion models of skin absorption","volume":"65","author":"Hansen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.02.016_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2007.06.020","article-title":"Partitioning, diffusivity and clearance of skin permeants in mammalian dermis","volume":"346","author":"Kretsos","year":"2008","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.02.016_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2007.06.001","article-title":"Investigation of drug partition property in artificial sebum","volume":"346","author":"Valiveti","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.016_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0013-9351(05)80112-4","article-title":"Pharmacokinetics of the dermal route of exposure to volatile organic chemicals in water: a computer simulation model","volume":"56","author":"Shatkin","year":"1991","journal-title":"Environ Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.016_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-3659(02)00321-8","article-title":"Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways","volume":"86","author":"Mitragotri","year":"2003","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.016_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00509031","article-title":"Rapid radial transport of methyl nicotinate in the dermis","volume":"273","author":"Guy","year":"1982","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.xphs.2021.02.016_bib32","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/S0006-3495(96)79457-2","article-title":"Lateral diffusion of small compounds in human stratum corneum and model lipid bilayer systems","volume":"71","author":"Johnson","year":"1996","journal-title":"Biophys J"},{"issue":"8","key":"10.1016\/j.xphs.2021.02.016_bib33","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.24028","article-title":"Topical formulations containing finasteride. Part I: in\u00a0vitro permeation\/penetration study and in\u00a0vivo pharmacokinetics in hairless rat","volume":"103","author":"Monti","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2021.02.016_bib34","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/jps.24045","article-title":"Topical formulations containing finasteride. Part II: determination of finasteride penetration into hair follicles using the differential stripping technique","volume":"103","author":"Tampucci","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2021.02.016_bib35","series-title":"Propecia Package Insert, Containing Prescribing Information","year":"2012"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.016_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5414\/CP202467","article-title":"Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia","volume":"54","author":"Caserini","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2021.02.016_bib37","series-title":"Clinical Evaluation of Topical Formulation of Finasteride in Male Androgenetic Alopecia","author":"Sitticharoenchai","year":"2006"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.016_bib39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.1989.46","article-title":"Absorption of minoxidil after topical application: effect of frequency and site of application","volume":"45","author":"Eller","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.xphs.2021.02.016_bib40","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1124\/dmd.114.058099","article-title":"Deciding on success criteria for predictability of pharmacokinetic parameters from in\u00a0vitro studies: an analysis based on in\u00a0vivo observations","volume":"42","author":"Abduljalil","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.016_bib41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cpt.904","article-title":"Reverse translation in PBPK and QSP: going backwards in order to go forward with confidence","volume":"103","author":"Rostami-Hodjegan","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2021.02.016_bib42","series-title":"Percutaneous Penetration Enhancers Drug Penetration Into\/Through the Skin: Methodology and General Considerations","first-page":"153","article-title":"Models, methods, and measurements in transdermal drug delivery","author":"Cropek","year":"2017"},{"key":"10.1016\/j.xphs.2021.02.016_bib43","first-page":"2065","article-title":"Skin barrier and transdermal drug delivery","volume":"3","author":"Prausnitz","year":"2012","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.xphs.2021.02.016_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.2042-7158.1979.tb13456.x","article-title":"Percutaneous absorption: in\u00a0vivo experiments","volume":"31","author":"Albery","year":"1979","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.016_bib45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/1523-1747.ep12470197","article-title":"The influence of stratum corneum morphology on water permeability","volume":"96","author":"Potts","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.xphs.2021.02.016_bib46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0009-9236(98)90054-6","article-title":"A\u00a0model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride","volume":"64","author":"Gisleskog","year":"1998","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.xphs.2021.02.016_bib47","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/cpt1972133436","article-title":"Pharmacokinetic studies of minoxidil","volume":"13","author":"Gottlieb","year":"1972","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.016_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2006.11.001","article-title":"Gender differences in drug responses","volume":"55","author":"Franconi","year":"2007","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.xphs.2021.02.016_bib50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1054-139X(94)90628-9","article-title":"Gender differences in human pharmacokinetics and pharmacodynamics","volume":"15","author":"Fletcher","year":"1994","journal-title":"J\u00a0Adolesc Health"},{"issue":"9","key":"10.1016\/j.xphs.2021.02.016_bib51","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/j.1552-4604.1989.tb03422.x","article-title":"Disposition of minoxidil in patients with various degrees of renal function","volume":"29","author":"Halstenson","year":"1989","journal-title":"J\u00a0Clin Pharmacol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:34:46Z","timestamp":1758360886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0022354921000952"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.02.016","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Qualification of a Physiologically Based Pharmacokinetic Model of Finasteride and Minoxidil Following Scalp Application","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}